InsiderWatch
Try it free

Patrick John Finn Insider Trades

President and COO

President and COO at Twist Bioscience Corp. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.

On EDGAR, this filer has 143 Form 4 filings on record since 2018, the latest on Nov 5, 2026. Full history on sec.gov

$0

Bought

$4.9M

Sold

0 / 1

Buys / Sells

1

Companies

Companies

  • TWSTPresident and COO

    Twist Bioscience Corp

    1 sell, $4.9M

Reported Trades

Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.

FiledCompanyTradeValue
Oct 5, 2026TWSTPresident and COOsell12.2% of stake$4.9M

Other Insiders at These Companies

Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.

  • Adam LaponisCFO at TWST1 sell, $1.5M
  • Paula GreenSVP of Human Resources at TWST1 sell, $1.9M
  • Dennis ChoSVP, Chief Legal Officer & Corporate Secretary at TWST1 sell, $1.8M
  • Katryn BlakeDirector at TWST1 sell, $275K

How to Read This Page

These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.

Get this insider's next buy when it files

InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.

Try free for 7 days

Every alert we send is logged with its timestamp and source.